JUBLPHARMAFinancial ResultsBSE
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026
Filed 30 October 2026 at 11:48 am · 52m ago
FILING SUBJECT
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2026